-
1
Sensitivity of mycobacterium leprae to telacebec
Published 2022Subjects: Get full text
Journal Article -
2
QcrB inhibition as a potential approach for the treatment of tuberculosis: A review of recent developments, patents, and future directions
Published 2023-06-01Subjects: Get full text
Article -
3
Naturally-occurring polymorphisms in QcrB are responsible for resistance to Telacebec in Mycobacterium abscessus
Published 2021Subjects: Get full text
Journal Article -
4
The Qcrb inhibitors TB47 and telacebec do not potentiate the activity of clofazimine in mycobacterium abscessus
Published 2022Subjects: Get full text
Journal Article -
5
Repurposing of Tuberculosis Drug Candidates for the Treatment of Mycobacterium ulcerans Disease
Published 2023-09-01Subjects: Get full text
Article -
6
Machine Learning Approaches to Predict Biological Effects of Organic Compounds
Published 2024-04-01Subjects: Get full text
Article -
7
Structure of mycobacterial CIII2CIV2 respiratory supercomplex bound to the tuberculosis drug candidate telacebec (Q203)
Published 2021-09-01Subjects: Get full text
Article -
8
Sensitivity of Mycobacterium leprae to Telacebec
Published 2022-03-01Subjects: Get full text
Article -
9
Telacebec Interferes with Virulence Lipid Biosynthesis Protein Expression and Sensitizes to Other Antibiotics
Published 2023-09-01Subjects: Get full text
Article -
10
Targeting the cytochrome oxidases for drug development in mycobacteria
Published 2020Subjects: Get full text
Journal Article